Literature DB >> 26315359

Tamoxifen-associated portal vein thrombosis causing severe oesophageal variceal bleeding.

Andrew Hsu1, Edward Belkin2, Samuel Han1, Randall Pellish2.   

Abstract

A 46-year-old woman with medical history of breast cancer on tamoxifen presented with syncope. On arrival to the hospital, the patient developed massive haematemesis and a subsequent esophagogastroduodenoscopy revealed oesophageal varices without any known history of liver disease. Further evaluation identified portal vein thrombosis probably caused by tamoxifen use. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26315359      PMCID： PMC4693120          DOI： 10.1136/bcr-2015-209988

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  18 in total

1.  Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study.

Authors:  Rohini K Hernandez; Henrik Toft Sørensen; Lars Pedersen; Jacob Jacobsen; Timothy L Lash
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

2.  Portal vein thrombosis after hepatectomy.

Authors:  Shohei Yoshiya; Ken Shirabe; Hidekazu Nakagawara; Yuji Soejima; Tomoharu Yoshizumi; Toru Ikegami; Yo-Ichi Yamashita; Norifumi Harimoto; Akihiro Nishie; Takeharu Yamanaka; Yoshihiko Maehara
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

3.  Effects of tamoxifen on blood coagulation.

Authors:  M J Auger; M J Mackie
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

4.  Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Authors:  Bernard Fisher; Joseph P Costantino; D Lawrence Wickerham; Reena S Cecchini; Walter M Cronin; Andre Robidoux; Therese B Bevers; Maureen T Kavanah; James N Atkins; Richard G Margolese; Carolyn D Runowicz; Joan M James; Leslie G Ford; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

Review 5.  Tamoxifen-associated Budd-Chiari syndrome complicated by heparin-induced thrombocytopenia and thrombosis: a case report and literature review.

Authors:  Maneerat Chayanupatkul; Ji Hyun Rhee; Anand Raman Kumar; Gabor Varadi
Journal:  BMJ Case Rep       Date:  2012-12-04

6.  Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in ten patients.

Authors:  K Ohnishi; K Okuda; T Ohtsuki; T Nakayama; Y Hiyama; S Iwama; N Goto; Y Nakajima; N Musha; T Nakashima
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

7.  Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis.

Authors:  M Coppens; J H Reijnders; S Middeldorp; C J M Doggen; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2008-06-06       Impact factor: 5.824

8.  Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy.

Authors:  R R Love; T S Surawicz; E C Williams
Journal:  Arch Intern Med       Date:  1992-02

9.  Effect of tamoxifen on measurements of hemostasis in healthy women.

Authors:  P M Mannucci; D Bettega; V Chantarangkul; A Tripodi; V Sacchini; U Veronesi
Journal:  Arch Intern Med       Date:  1996-09-09

Review 10.  Idiopathic non-cirrhotic portal hypertension: a review.

Authors:  Jeoffrey N L Schouten; Joanne Verheij; Susana Seijo
Journal:  Orphanet J Rare Dis       Date:  2015-05-30       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.